期刊文献+

COX-2基因多态性与食管癌易感性关系的Meta分析 被引量:2

COX-2 Polymorphism and Susceptibility to Esophageal Cancer: A Meta-analysis
原文传递
导出
摘要 目的探讨COX-2基因多态性与食管癌易感性的关系。方法计算机检索PubMed和EMbase数据库,检索时间截至2011年1月1日,获取COX-2基因多态性与食管癌易感性关系的病例-对照研究。以食管癌组与对照组人群基因型分布的OR值及其95%CI为效应指标,在纯合子模型、显性模型和隐性模型中采用固定或随机效应模型进行Meta分析,并进行发表偏倚评估。统计分析采用Stata 11.0软件。结果共纳入5个病例-对照研究。Meta分析结果显示:在COX-2-765G>C多态性位点,显性模型中,与野生基因型GG相比,CC+GC合并的OR值(95%CI)为1.806(1.050,3.106),其余为阴性结果。在COX-2-1195G>A多态性位点中,纯合子模型、显性模型及隐性模型均为阳性结果。结论 COX-2基因多态性与食管癌易感性可能相关。 Objective To investigate the relationship between cyclooxygenase-2(COX-2) gene polymorphism and genetic susceptibility to esophageal cancer.Methods e PubMed and EMbase databases were searched from the date of their establishment to January 1st,2011 to collect the case-control studies on COX-2 polymorphism and susceptibility to esophageal cancer.For the population genotype distributions of both esophagus cancer group and control group,their odds ratios(ORs) and 95% con dence intervals(CIs) were taken as the e ect indexes,either the xed or random e ect model was applied to conducted Meta-analysis in homozygote comparison,dominant and recessive genetic models,and the publication bias was assessed then.All statistical analyses were conducted with Stata11.0 so ware.Results A total of ve case-control studies were included.e results of meta-analyses showed for the COX-2-765GC polymorphism,the CC+GC genotype was associated with the risk of esophageal cancer in a dominant genetic model(CC+GC vs.GG: OR=1.806,95% CI 1.050 to 3.106);for the COX-2-1195GA polymorphism,the AA genotype was associated with the risk of esophageal cancer in homozygote comparison and recessive genetic models,the AA+GA genotype was associated with the risk of esophageal cancer in a dominant genetic model.Conclusion It is suggested that COX-2 polymorphism may be associated with genetic susceptibility to esophageal cancer.
出处 《中国循证医学杂志》 CSCD 2011年第12期1391-1394,共4页 Chinese Journal of Evidence-based Medicine
关键词 COX-2 食管癌 基因多态性 病例-对照研究 META分析 COX-2 Esophageal cancer Gene polymorphism Case-control study Meta-analysis
  • 相关文献

参考文献6

二级参考文献2

共引文献50

同被引文献23

  • 1曾超,贺修胜,罗桥,赵帅,邓敏.胃癌中RUNX3蛋白表达与胃癌关系的研究[J].癌变.畸变.突变,2006,18(6):455-458. 被引量:3
  • 2Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin, 2005, 55(2): 74-108. 被引量:1
  • 3Bangsow C, Rubins N, Glusman G, et al. TheRUNX3 gene-sequence, structure and regulated expression. Gene, 2001, 279(2): 221-232. 被引量:1
  • 4Li QL, Ito K, Sakakura C, et al. Causal relationship betweenthe loss of RUNX3 expression and gastric cancer. Cell, 2002, 109(1): 113-124. 被引量:1
  • 5Lau QC, Raja E, Salto-tellez M, et al. RUNX3 is frequently inacti- vated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Res, 2006, 66(13): 6512- 6520. 被引量:1
  • 6Takahashi T, Shivapurkar N, Riquelme E, et al. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis. Clin Cancer Res, 2004, 10(18 Pt1): 6126-6133. 被引量:1
  • 7Bae SC, Choi IK. Tumor suppressor activity of RUNX3. Oncogene, 2004, 23(24): 4336-4340. 被引量:1
  • 8Wells G A, Shea B, O'connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 3rd Symposium on Systematic Reviews: Beyond the Basics. 2000. 被引量:1
  • 9Stang A. Critical evaluation of the Newcastle-Ottawa scale for the as- sessment of the quality of nonrandomized studies in meta-analyses. European Journal of Epidemiology, 2010, 25(9): 603-605. 被引量:1
  • 10Taniuchi I, Osato M, Egawa T, et al. Differential requirements for Runx proteins in CD4 repressionand epigenetic silencing during T lymphocyte development. Cell, 2002, 111(5): 621-633. 被引量:1

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部